140 related articles for article (PubMed ID: 8928622)
1. No correlation between nigral degeneration and striatal plaques in Alzheimer's disease.
Love S; Wilcock GK; Matthews SM
Acta Neuropathol; 1996; 91(4):432-6. PubMed ID: 8928622
[TBL] [Abstract][Full Text] [Related]
2. Decreased nigral neuromelanin in Alzheimer's disease.
Reyes MG; Faraldi F; Rydman R; Wang CC
Neurol Res; 2003 Mar; 25(2):179-82. PubMed ID: 12635519
[TBL] [Abstract][Full Text] [Related]
3. Neuropathological features of Alzheimer's disease in non-demented parkinsonian patients.
Daniel SE; Lees AJ
J Neurol Neurosurg Psychiatry; 1991 Nov; 54(11):972-5. PubMed ID: 1800669
[TBL] [Abstract][Full Text] [Related]
4. Histopathology of the substantia nigra in Alzheimer's disease.
Reyes MG; Faraldi F; Chandran R; Verano A; Levi AC
Panminerva Med; 1996 Mar; 38(1):8-14. PubMed ID: 8766873
[TBL] [Abstract][Full Text] [Related]
5. A pathological study of the association between Lewy body disease and Alzheimer's disease.
Gibb WR; Mountjoy CQ; Mann DM; Lees AJ
J Neurol Neurosurg Psychiatry; 1989 Jun; 52(6):701-8. PubMed ID: 2545826
[TBL] [Abstract][Full Text] [Related]
6. The substantia nigra and ventral tegmental area in Alzheimer's disease and Down's syndrome.
Gibb WR; Mountjoy CQ; Mann DM; Lees AJ
J Neurol Neurosurg Psychiatry; 1989 Feb; 52(2):193-200. PubMed ID: 2539435
[TBL] [Abstract][Full Text] [Related]
7. Neuropathological correlates of dopaminergic imaging in Alzheimer's disease and Lewy body dementias.
Colloby SJ; McParland S; O'Brien JT; Attems J
Brain; 2012 Sep; 135(Pt 9):2798-808. PubMed ID: 22961551
[TBL] [Abstract][Full Text] [Related]
8. Neuropathology of parkinsonism in patients with pure Alzheimer's disease.
Horvath J; Burkhard PR; Herrmann FR; Bouras C; Kövari E
J Alzheimers Dis; 2014; 39(1):115-20. PubMed ID: 24121968
[TBL] [Abstract][Full Text] [Related]
9. Apoptotic-like changes in Lewy-body-associated disorders and normal aging in substantia nigral neurons.
Tompkins MM; Basgall EJ; Zamrini E; Hill WD
Am J Pathol; 1997 Jan; 150(1):119-31. PubMed ID: 9006329
[TBL] [Abstract][Full Text] [Related]
10. Sex differences for clinical correlates of substantia nigra neuron loss in people with Lewy body pathology.
Bayram E; Coughlin DG; Rajmohan R; Litvan I
Biol Sex Differ; 2024 Jan; 15(1):8. PubMed ID: 38243325
[TBL] [Abstract][Full Text] [Related]
11. Substantia nigra lesions in Alzheimer disease and normal aging.
Kazee AM; Cox C; Richfield EK
Alzheimer Dis Assoc Disord; 1995; 9(2):61-7. PubMed ID: 7662324
[TBL] [Abstract][Full Text] [Related]
12. Parkinson's disease without nigral degeneration: a pathological correlate of scans without evidence of dopaminergic deficit (SWEDD)?
Ling H; Kearney S; Yip HL; Silveira-Moriyama L; Revesz T; Holton JL; Strand C; Davey K; Mok KY; Polke JM; Lees AJ
J Neurol Neurosurg Psychiatry; 2016 Jun; 87(6):633-41. PubMed ID: 26209716
[TBL] [Abstract][Full Text] [Related]
13. Cortical Lewy bodies in Alzheimer's disease.
Kazee AM; Han LY
Arch Pathol Lab Med; 1995 May; 119(5):448-53. PubMed ID: 7748074
[TBL] [Abstract][Full Text] [Related]
14. Striatal dopaminergic markers in dementia with Lewy bodies, Alzheimer's and Parkinson's diseases: rostrocaudal distribution.
Piggott MA; Marshall EF; Thomas N; Lloyd S; Court JA; Jaros E; Burn D; Johnson M; Perry RH; McKeith IG; Ballard C; Perry EK
Brain; 1999 Aug; 122 ( Pt 8)():1449-68. PubMed ID: 10430831
[TBL] [Abstract][Full Text] [Related]
15. Alteration in nicotine binding sites in Parkinson's disease, Lewy body dementia and Alzheimer's disease: possible index of early neuropathology.
Perry EK; Morris CM; Court JA; Cheng A; Fairbairn AF; McKeith IG; Irving D; Brown A; Perry RH
Neuroscience; 1995 Jan; 64(2):385-95. PubMed ID: 7700528
[TBL] [Abstract][Full Text] [Related]
16. Striatonigral degeneration combined with Alzheimer's disease.
Kosaka K; Iizuka R; Mizutani Y; Kondo T; Nagatsu T
Acta Neuropathol; 1981; 54(3):253-6. PubMed ID: 6114611
[TBL] [Abstract][Full Text] [Related]
17. Pathological correlates of extrapyramidal signs in Alzheimer's disease.
Liu Y; Stern Y; Chun MR; Jacobs DM; Yau P; Goldman JE
Ann Neurol; 1997 Mar; 41(3):368-74. PubMed ID: 9066358
[TBL] [Abstract][Full Text] [Related]
18. Apolipoprotein E epsilon4 is associated with neuronal loss in the substantia nigra in Alzheimer's disease.
Camicioli R; Kaye J; Payami H; Ball MJ; Murdoch G
Dement Geriatr Cogn Disord; 1999; 10(6):437-41. PubMed ID: 10559556
[TBL] [Abstract][Full Text] [Related]
19. Distribution of basal ganglia lesions in diffuse neurofibrillary tangles with calcification: a clinicopathological study of five autopsy cases.
Tsuchiya K; Nakayama H; Iritani S; Arai T; Niizato K; Haga C; Matsushita M; Ikeda K
Acta Neuropathol; 2002 Jun; 103(6):555-64. PubMed ID: 12012087
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin II receptor binding associated with nigrostriatal dopaminergic neurons in human basal ganglia.
Allen AM; MacGregor DP; Chai SY; Donnan GA; Kaczmarczyk S; Richardson K; Kalnins R; Ireton J; Mendelsohn FA
Ann Neurol; 1992 Sep; 32(3):339-44. PubMed ID: 1416803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
